EP
MET icon

Eudaimonia Partners’s MetLife MET Stock Holding History

Eudaimonia Partners’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,641
Closed -$211K – 361
2023
Q1 		$211K Sell
3,641
-67
-2% -$4.52K 0.05% 317
2022
Q4 		$268K Buy
3,708
+72
+2% +$5.16K 0.07% 271
2022
Q3 		$221K Sell
3,636
-115
-3% -$7.35K 0.06% 292
2022
Q2 		$236K Buy
3,751
+271
+8% +$17.9K 0.04% 336
2022
Q1 		$245K Buy
+3,480
New +$235K 0.04% 347
2021
Q3 		$208K Sell
3,367
-15
-0.4% -$903 0.04% 364
2021
Q2 		$202K Buy
3,382
+20
+0.6% +$1.27K 0.04% 369
2021
Q1 		$205K Sell
3,362
-9
-0.3% -$497 0.04% 330
2020
Q4 		$158K Buy
3,371
+26
+0.8% +$1.13K 0.04% 348
2020
Q3 		$124K Sell
3,345
-63
-2% -$2.39K 0.03% 364
2020
Q2 		$124K Sell
3,408
-196
-5% -$6.82K 0.05% 316
2020
Q1 		$111K Sell
3,604
-704
-16% -$31.2K 0.05% 313
2019
Q4 		$219K Buy
+4,308
New +$208K 0.09% 223

Other funds holding MET

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Eudaimonia Partners's MET Position: Q2 2023 in Review

Eudaimonia Partners sold out of MetLife (MET) in Q2 2023, closing a stake of 3,641 shares — an estimated $211K sold.

Eudaimonia Partners first reported a position in MET in Q4 2019 and held it in 13 quarters. The position peaked at $268K in Q4 2022. 1,171 funds tracked by Wall St. Rank hold MET as of Q2 2023.

  • Eudaimonia Partners reported no remaining MetLife position as of Q2 2023 after selling out during the quarter.
  • Eudaimonia Partners sold 3,641 MetLife shares in Q2 2023, an estimated $211K.
  • Eudaimonia Partners first reported a position in MetLife in Q4 2019 and held it in 13 quarters.
  • Eudaimonia Partners's MetLife position peaked at $268K in Q4 2022.
  • 1,171 funds tracked by Wall St. Rank held MetLife as of Q2 2023.

Based on Eudaimonia Partners's 13F filing for Q2 2023, filed 19 Jul 2023.